MorViva: PTIE completed enrollment of 160 patients in a double-blind Phase II trial comparing the analgesic efficacy and safety of MorViva to a commercially ava

Pain Therapeutics Inc. (PTIE), South San Francisco, Calif. Product: MorViva (PTI-555) Business: Neurological Therapeutic category: Analgesic, Receptor antagonist Target: Opioid receptors Description: ...